Acute Myeloid Leukemia with Del
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia with Del.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy [Phase 2]
Phase 2 trial evaluating the combination of sirolimus and azacitidine in adults with high-risk myelodysplastic syndrome or acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial updating the use of off-the-shelf expanded cord blood cells to augment cord blood transplant in patients with various…
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission [Phase 1]
Phase 1 trial update evaluating a cancer vaccine therapy in combination with Basiliximab for adults with acute myeloid leukemia (in remissio…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update of ixazomib in relapsed or refractory acute myeloid leukemia has been terminated; results were posted previous…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
A Phase I trial evaluating a combination of midostaurin and bortezomib with chemotherapy in relapsed/refractory acute myeloid leukemia has c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
This Phase 2 trial updates romidepsin for relapsed or refractory acute myeloid leukemia, covering several AML subtypes defined by cytogeneti…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating AKT inhibitor MK-2206 in relapsed or refractory adult acute leukemias completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating bortezomib in combination with chemotherapy for younger patients with recurrent, refractory, or secondary acute m…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies [Phase 2]
Phase 2 trial updating the use of deferasirox for iron overload due to transfusions in patients with hematologic malignancies; study status …
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [Phase 3]
Phase 3 trial evaluating low-dose or high-dose conditioning regimens before peripheral blood stem cell transplantation in patients with myel…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases [Phase 1]
This Phase 1 trial evaluates the safety and feasibility of combining vorinostat with decitabine in adults with relapsed, refractory, or poor…